BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
BIOHARVEST SCIENCES INC.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.80−0.05 (-2.70%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$9.25 (−83.71%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
BIOHARVEST SCIENCES INC. grew revenue 37.0% to $34.51M over fiscal 2025. Free cash flow was -$9.58M.
Revenue
$34.51M
+37.0% vs. a year earlier
Operating income
-$5.58M
FY2025
Free cash flow
-$9.58M
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $34.51M
- Net income
- -$11.14M
- Free cash flow
- -$9.58M
Four years at a glance
Fiscal years 2022 to 2025, USD
Revenue
$34.51M+37.0% YoY
Gross profit
$20.48M+46.9% YoY
Operating income
-$5.58M
Net income
-$11.14M
Free cash flow
-$9.58M
Reported period